A phase II trial of hippocampus sparing in whole-brain radiotherapy in patients with multiple brain tumors: cognitive function and quality-of-life results

A phase II trial of hippocampus sparing in whole-brain radiotherapy in patients with multiple brain tumors: cognitive function and quality-of-life results - hippocampus sparing in whole-brain radiotherapy for multiple brain tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014920

Enrollment

Registered

2014-09-01

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic brain tumors and primary central nervous system lymphoma

Interventions

hippocampul sparing whole brain radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Metastatic brain tumors and primary central nervous system lymphoma

Exclusion criteria

Exclusion criteria: Cerebrospinal fluid dissemination 1 to 3 tumors, under 3cm diameter

Design outcomes

Primary

Measure	Time frame
Cognitive function, Quality of life and over all survival	—

Countries

Japan

Contacts

Public ContactYuzo Hasegawa

Chiba Cancer Center Neurological Surgery

yhasegawa@chiba-cc.jp043-264-5431

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026